Loading stock…

Cencora, Inc. (COR) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Cencora, Inc.

CORMarket cap $61BPrice $317.3

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Distributes prescription drugs and medical supplies to hospitals, pharmacies, and clinics across America. Handles roughly 20% of all pharmaceutical distribution in the US, making it a critical middleman in healthcare's supply chain.

In Bastion Portfolios?

52W Return-2%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+10%7

Revenue Forecast

Rev CAGR (1y)+5%4

Rev CAGR (3y)+5%4

Rev CAGR (5y)+5%5

Earnings Forecast

EPS Growth Y+1+129%10

EPS Growth Y+2+9%6

EPS Growth Y+3+8%6

Quality

Margins

EBIT Margin1%2

Net Income Margin1%2

Free Cash Flow Margin1%3

Debt

Net Debt/EBITDA2.04

Efficiency

ROE104%10

ROA3%5

Earnings Stability77

GEAR+AVERAGE55

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)165

P/E Ratio (Forward 3y)155

P/BV19.81

EV Multiples

EV/EBITDA Fwd134

EV/EBIT Fwd156

Yield

Free Cash Flow Yield6.7%8

Dividend Yield0.8%2

Momentum

Short term

1 month return-2%7

3 month return+3%7

YTD return-6%4

Mid term

Price vs 52wHigh85%6

1 year return+3%5

Long term

3 year return+77%7

5 year return+179%9

Risk Shield

Price Risk

Beta0.110

Volatility32%6

Free Cash Flow

Free Cash Flow Margin1%3

Free Cash Flow Yield6.7%8

Quality

ROCE20%9

Earnings Stability77

Net Debt/EBITDA2.04

02Growth

Is it actually growing, and how fast?

CORCencora

Revenue FY25$321B

GROWTH RATING↗

AVERAGE45 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+129%10

EPS growth, FY27E+9%6

EPS growth, FY28E+8%6

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Earnings are set to grow in step with sales (EPS about 9%/yr vs revenue 5%/yr).

WATCH

A mid-pack grower, ahead of 45% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 10%/yr over the last 3 years; forecasts see it cooling to 5%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG70 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return+3%7

YTD return-6%4

MID & LONG-TERM▾SCORE

% of 52-week high85%6

1-year return+3%5

3-year return+77%7

5-year return+179%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +77% over three years and +179% over five, ahead of 70% of the market.

Strong recent results. The stock is outperforming over the past month (-2%) and over three months (+3%).

WATCH

It's up 3% over the past year, but 15% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (-6%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Cencora. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CORCencora

Revenue FY25$321B

GROWTH RATING↗

AVERAGE45 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+129%10

EPS growth, FY27E+9%6

EPS growth, FY28E+8%6

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Earnings are set to grow in step with sales (EPS about 9%/yr vs revenue 5%/yr).

WATCH

A mid-pack grower, ahead of 45% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 10%/yr over the last 3 years; forecasts see it cooling to 5%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG70 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return+3%7

YTD return-6%4

MID & LONG-TERM▾SCORE

% of 52-week high85%6

1-year return+3%5

3-year return+77%7

5-year return+179%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +77% over three years and +179% over five, ahead of 70% of the market.

Strong recent results. The stock is outperforming over the past month (-2%) and over three months (+3%).

WATCH

It's up 3% over the past year, but 15% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (-6%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Cencora. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community